Loading...
Chemed Corporation
CHE•NYSE
HealthcareMedical - Care Facilities
$561.93
$1.16(0.21%)
Chemed Corporation (CHE) Financial Performance & Statements
Review Chemed Corporation’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
7.37%
↑ 7.37%
Operating Income Growth
7.61%
↑ 7.61%
Net Income Growth
10.82%
↑ 10.82%
Operating Cash Flow Growth
26.40%
↑ 26.40%
Operating Margin
15.63%
↑ 15.63%
Gross Margin
33.54%
↑ 33.54%
Net Profit Margin
12.40%
↑ 12.40%
ROE
26.03%
↑ 26.03%
ROIC
27.08%
↑ 27.08%
Chemed Corporation (CHE) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Chemed Corporation stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $639.99M | $606.18M | $595.88M | $589.23M |
| Cost of Revenue | $405.88M | $396.19M | $405.46M | $400.94M |
| Gross Profit | $234.12M | $209.99M | $190.42M | $188.30M |
| Gross Profit Ratio | $0.37 | $0.35 | $0.32 | $0.32 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $104.25M | $101.98M | $102.25M | $115.87M |
| Operating Expenses | $120.24M | $117.84M | $102.29M | $115.97M |
| Total Costs & Expenses | $526.12M | $514.02M | $507.75M | $516.90M |
| Interest Income | $3.21M | $3.67M | $3.50M | $4.24M |
| Interest Expense | $499000.00 | $427000.00 | $429000.00 | $425000.00 |
| Depreciation & Amortization | $15.83M | $15.70M | $15.71M | $15.81M |
| EBITDA | $136.45M | $117.15M | $103.84M | $88.14M |
| EBITDA Ratio | $0.21 | $0.19 | $0.17 | $0.15 |
| Operating Income | $113.88M | $92.16M | $88.13M | $72.33M |
| Operating Income Ratio | $0.18 | $0.15 | $0.15 | $0.12 |
| Other Income/Expenses (Net) | $6.25M | $8.87M | $5.70M | $12.15M |
| Income Before Tax | $120.12M | $101.03M | $93.83M | $84.48M |
| Income Before Tax Ratio | $0.19 | $0.17 | $0.16 | $0.14 |
| Income Tax Expense | $29.80M | $25.25M | $22.94M | $19.47M |
| Net Income | $90.32M | $75.78M | $70.89M | $65.02M |
| Net Income Ratio | $0.14 | $0.13 | $0.12 | $0.11 |
| EPS | $6.08 | $5.04 | $4.70 | $4.30 |
| Diluted EPS | $6.02 | $5.02 | $4.65 | $4.24 |
| Weighted Avg Shares Outstanding | $14.85M | $15.03M | $15.10M | $15.12M |
| Weighted Avg Shares Outstanding (Diluted) | $14.99M | $15.08M | $15.25M | $15.34M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan